Short Interest in Sonova Holding (OTCMKTS:SONVY) Expands By 41.2%

Sonova Holding (OTCMKTS:SONVY) was the target of a large growth in short interest in February. As of February 13th, there was short interest totaling 11,643 shares, a growth of 41.2% from the January 29th total of 8,247 shares. Based on an average daily volume of 50,154 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.0% of the company’s shares are sold short. Currently, 0.0% of the company’s shares are sold short. Based on an average daily volume of 50,154 shares, the days-to-cover ratio is currently 0.2 days.

Sonova Price Performance

Shares of OTCMKTS SONVY opened at $52.08 on Monday. Sonova has a 1 year low of $47.55 and a 1 year high of $68.76. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.24 and a quick ratio of 0.91. The firm has a 50-day moving average of $53.03 and a 200 day moving average of $54.08.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on SONVY shares. Zacks Research raised shares of Sonova from a “strong sell” rating to a “hold” rating in a research note on Monday, February 9th. Royal Bank Of Canada upgraded shares of Sonova to a “moderate buy” rating in a report on Tuesday, November 18th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, four have assigned a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, Sonova has a consensus rating of “Hold”.

About Sonova

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.